Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.930
-0.130 (-12.25%)
At close: Apr 28, 2026, 4:00 PM EDT
0.916
-0.014 (-1.52%)
Pre-market: Apr 29, 2026, 4:23 AM EDT
Skye Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -55.92 | -26.57 | -37.64 | -19.48 | -8.52 | |
| Depreciation & Amortization | 0.72 | 0.3 | 0.12 | 0.11 | 0.03 | |
| Other Amortization | - | 0.6 | 0.33 | 0.49 | 0.59 | |
| Loss (Gain) From Sale of Assets | -0.36 | -1.35 | 0.3 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 21.22 | - | - | |
| Stock-Based Compensation | 7.77 | 8.32 | 0.99 | 0.63 | 0.87 | |
| Other Operating Activities | - | -3.91 | 1.2 | 6.27 | -0.1 | |
| Change in Accounts Payable | 1.4 | -0.59 | -0.7 | 0.8 | 0.52 | |
| Change in Other Net Operating Assets | 3.34 | -2.04 | 0.23 | -1.56 | 0.13 | |
| Operating Cash Flow | -43.06 | -25.24 | -13.95 | -12.74 | -6.47 | |
| Capital Expenditures | -0.01 | -1.6 | -0.01 | -0.09 | -0.09 | |
| Sale of Property, Plant & Equipment | 0.36 | 1.36 | 5.53 | - | - | |
| Cash Acquisitions | - | - | 1.08 | 5.31 | - | |
| Investment in Securities | -19.85 | - | - | - | - | |
| Investing Cash Flow | -19.5 | -0.25 | 6.6 | 5.21 | -0.09 | |
| Short-Term Debt Issued | - | - | 4.97 | - | - | |
| Long-Term Debt Issued | - | - | - | 0.68 | - | |
| Total Debt Issued | - | - | 4.97 | 0.68 | - | |
| Long-Term Debt Repaid | - | - | -0.26 | -0.89 | - | |
| Net Debt Issued (Repaid) | - | - | 4.71 | -0.21 | - | |
| Issuance of Common Stock | - | 90 | 12 | 0 | 14.01 | |
| Other Financing Activities | 0.03 | -6.43 | -0.27 | - | -0.94 | |
| Financing Cash Flow | 0.03 | 83.56 | 16.44 | -0.21 | 13.08 | |
| Net Cash Flow | -62.53 | 58.08 | 9.09 | -7.74 | 6.51 | |
| Free Cash Flow | -43.07 | -26.84 | -13.96 | -12.84 | -6.57 | |
| Free Cash Flow Per Share | -1.09 | -0.74 | -1.99 | -5.78 | -4.04 | |
| Cash Interest Paid | - | 0.43 | 0.2 | 0.33 | 0.04 | |
| Cash Income Tax Paid | 0.01 | 0.01 | 0 | 0.01 | 0 | |
| Levered Free Cash Flow | -22.95 | -9.05 | -11.04 | -9.44 | -3.28 | |
| Unlevered Free Cash Flow | -22.95 | -9.18 | -10.8 | -9.51 | -3.39 | |
| Change in Working Capital | 4.73 | -2.63 | -0.47 | -0.76 | 0.65 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.